![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 26618-26622, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
§,
¶
From the Departments of Sex hormone-binding globulin (SHBG) is a
plasma protein synthesized and secreted by the liver. Its initial
description stemmed from its ability to bind estrogens and androgens
and its capacity to regulate the free concentration of the
steroids that bind to it. Additionally, it participates in signal
transduction for certain steroid hormones at the cell membrane. It
binds with high affinity to a specific membrane receptor
(RSHBG) in prostate stromal and epithelial cells,
wherein the SHBG·RSHBG complex forms. An
appropriate steroid binds to this complex and results in increases of
intracellular cAMP. These two disparate functions of SHBG, regulation
of the concentration of free steroids in plasma and signal transduction in selected tissues, raise the question of how its synthesis and secretion might be regulated so as to best perform these two disparate functions. In this paper we demonstrate that SHBG is produced in human
prostate cancer cell lines (LNCaP, DU 145, and PC 3) as well as in
cultured human prostate epithelial and stromal cells. In addition, in
tissue sections of human prostate, we demonstrate the presence of SHBG
(immunocytochemistry) and SHBG mRNA (in situ hybridization). These observations are consistent with the hypothesis that SHBG, destined to participate in signaling at the cell membrane, is locally regulated and produced.
Medicine and
§ Urology, St. Luke's/Roosevelt Hospital
Center, and College of Physicians and Surgeons, Columbia University,
New York, New York 10019
This article has been cited by other articles:
![]() |
J. Bobe, S. Mahe, T. Nguyen, H. Rime, D. Vizziano, A. Fostier, and Y. Guiguen A Novel, Functional, and Highly Divergent Sex Hormone-Binding Globulin that May Participate in the Local Control of Ovarian Functions in Salmonids Endocrinology, June 1, 2008; 149(6): 2980 - 2989. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I Scher, G. Buchanan, W. Gerald, L. M Butler, and W. D Tilley Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer Endocr. Relat. Cancer, September 1, 2004; 11(3): 459 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Mohler, C. W. Gregory, O. H. Ford III, D. Kim, C. M. Weaver, P. Petrusz, E. M. Wilson, and F. S. French The Androgen Axis in Recurrent Prostate Cancer Clin. Cancer Res., January 15, 2004; 10(2): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |